1. Kashtan, Clifford E. 2020. Alport Syndrome: Achieving Early Diagnosis and Treatment. In American journal of kidney diseases : the official journal of the National Kidney Foundation, 77, 272-279. doi:10.1053/j.ajkd.2020.03.026. https://pubmed.ncbi.nlm.nih.gov/32712016/
2. Yuan, Xiaohan, Su, Qing, Wang, Hui, Zhu, Li, Zhang, Hong. 2022. Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients. In Journal of the American Society of Nephrology : JASN, 34, 132-144. doi:10.1681/ASN.2021111447. https://pubmed.ncbi.nlm.nih.gov/36130833/
3. Savige, Judy, Renieri, Alessandra, Ars, Elisabet, Lipska-Zietkiewicz, Beata, Gibson, Joel T. 2022. Digenic Alport Syndrome. In Clinical journal of the American Society of Nephrology : CJASN, 17, 1697-1706. doi:10.2215/CJN.03120322. https://pubmed.ncbi.nlm.nih.gov/35675912/
4. Bekheirnia, Mir Reza, Reed, Berenice, Gregory, Martin C, Masoumi, Amirali, Schrier, Robert W. 2010. Genotype-phenotype correlation in X-linked Alport syndrome. In Journal of the American Society of Nephrology : JASN, 21, 876-83. doi:10.1681/ASN.2009070784. https://pubmed.ncbi.nlm.nih.gov/20378821/
5. De Silva, Samantha R, Arno, Gavin, Robson, Anthony G, Webster, Andrew R, Mahroo, Omar A. 2020. The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. In Progress in retinal and eye research, 82, 100898. doi:10.1016/j.preteyeres.2020.100898. https://pubmed.ncbi.nlm.nih.gov/32860923/
6. Xu, Zhenjian, Chen, Junzhe, Yu, Wenjuan, Xu, Anping, Tang, Ying. 2020. New COL4A5 mutation in IgA nephropathy. In Postgraduate medical journal, 98, 13-17. doi:10.1136/postgradmedj-2020-138625. https://pubmed.ncbi.nlm.nih.gov/33087535/
智鼠故事 
